IBB Among Technology ETFs
End-of-day Nov 19, 2026 · 44 Technology ETFs by 3Y
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −0.8% | −4.5% | −3.7% | −4.6% | +20.8% | +22.6% | +74.0% | +34.5% | +120.0% | +683.5% |
| Peer average | −2.0% | −7.0% | −12.3% | −14.4% | 0.0% | +3.7% | +57.2% | +20.1% | +352.7% | — |
| S&P 500 · VOO | −2.0% | −5.5% | −7.4% | −6.3% | +5.8% | +9.7% | +65.8% | +65.5% | +290.0% | — |
$94 of every $1,000 in IBB is Gilead
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | GILDGilead Sciences | Healthcare | 9.37% | $937.38 | 6.0M | $1.02B |
| 2 | AMGNAmgen | Healthcare | 8.38% | $838.25 | 2.1M | $912.6M |
| 3 | VRTXVertex Pharmaceuticals | Healthcare | 8.00% | $799.76 | 1.6M | $870.7M |
| 4 | REGNRegeneron Pharmaceuticals | Healthcare | 6.73% | $673.17 | 775K | $732.9M |
| 5 | MRNAModerna | Healthcare | 5.16% | $516.40 | 2.9M | $562.2M |
| 6 | ARGXArgenx SE | Healthcare | 3.76% | $375.68 | 435K | $409.0M |
| 7 | NTRANatera | Healthcare | 2.80% | $279.99 | 1.1M | $304.8M |
| 8 | BIIBBiogen | Healthcare | 2.65% | $264.85 | 1.1M | $288.3M |
| 9 | ONCBeone Medicines AG | Healthcare | 2.44% | $243.87 | 658K | $265.5M |
| 10 | ILMNIllumina | Healthcare | 2.27% | $227.20 | 1.2M | $247.4M |
| 11 | RVMDRevolution Medicines | Healthcare | 2.21% | $221.32 | 1.5M | $241.0M |
| 12 | GMABGenmab Sponsored | Healthcare | 2.03% | $202.80 | 4.3M | $220.8M |
| 13 | INSMInsmed | Healthcare | 1.85% | $185.13 | 1.7M | $201.6M |
| 14 | UTHRUnited Therapeutics | Healthcare | 1.72% | $171.94 | 324K | $187.2M |
| 15 | INCYIncyte | Healthcare | 1.70% | $169.97 | 1.6M | $185.1M |
of the $345B in 58 Technology ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | GILD | Gilead Sciences | 9.37% |
| 2 | AMGN | Amgen | 8.38% |
| 3 | VRTX | Vertex Pharmaceuticals | 8.00% |
| 4 | REGN | Regeneron Pharmaceuticals | 6.73% |
| 5 | MRNA | Moderna | 5.16% |
| 6 | ARGX | Argenx SE | 3.76% |
| 7 | NTRA | Natera | 2.80% |
| 8 | BIIB | Biogen | 2.65% |
| 9 | ONC | Beone Medicines AG | 2.44% |
| 10 | ILMN | Illumina | 2.27% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 15, 2026 | Sep 18, 2026 | $0.0112 |
| Jun 15, 2026 | Jun 18, 2026 | $0.0238 |
| Mar 17, 2026 | Mar 20, 2026 | $0.12 |
| Dec 16, 2025 | Dec 19, 2025 | $0.18 |
| Sep 16, 2025 | Sep 19, 2025 | $0.0828 |
| Mar 18, 2025 | Mar 21, 2025 | $0.12 |
| Dec 17, 2024 | Dec 20, 2024 | $0.0624 |
| Sep 25, 2024 | Sep 30, 2024 | $0.20 |
| Mar 21, 2024 | Mar 27, 2024 | $0.13 |
| Dec 20, 2023 | Dec 27, 2023 | $0.12 |
| Sep 26, 2023 | Oct 2, 2023 | $0.15 |
| Jun 7, 2023 | Jun 13, 2023 | $0.0062 |